Breast Imaging Market
Breast Imaging Market - Global Industry Assessment & Forecast
Segments Covered
- By Type of Imaging Technique Mammography, Breast Ultrasound, Breast MRI, Image-guided breast biopsy, Other Imaging Techniques
- By End Users Hospitals, Diagnostic Centers, Others
- By Regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 3897.55 Million |
Revenue 2030: | USD 6899.62 Million |
Revenue CAGR (2023 - 2030): | 7.40% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Market Synopsis
Global breast imaging market is valued at USD 3897.55 Million in 2022 and is projected to reach a value of USD 6899.62 Million by 2030 at a CAGR of 7.40% over the forecast period. Breast imaging is a subspecialty of diagnostic radiology that uses ionizing or non-ionizing radiation to detect tumors in the breast. This technique allows clinicians to make an early diagnosis before the actual symptoms are present. The development of hybrid imaging systems and the extensive research in the development of hybrid imaging systems provide the market with significant growth opportunities over the forecast period. The global incidence of breast cancer is rising, and the burden of women with a backlog of cancer screening appointments due to COVID-19, has underlined the importance of women’s health and early detection of cancer. Breast cancer is expected to become the most diagnosed cancer, surpassing lung cancer as the most prevalent. The heightened expectations for government screening programs are a result of the world's steady increase in breast cancer incidence. To reduce breast cancer mortality, screening programs alone are not enough, accuracy in breast cancer detection must be improved, while false positives and missed lesions must also be reduced. These factors are expected to be at the forefront of breast imaging for both screening and diagnosis. The breast imaging market is fueled by stronger awareness of the benefits of breast cancer screening programs, as well as the need to improve breast cancer detection accuracy. This, along with a patient-centric approach to screening and technological advances to improve patient comfort, are among the methods being employed to improve participation in screening programs, which in turn has boosted the adoption of mammography X-ray equipment.
Market Segmentation:
The global breast imaging market is classified into type of imaging technique, end user, and region. On the basis of type of imaging technique, the target market is bifurcated as mammography, breast ultrasound, breast MRI, image-guided breast biopsy and other imaging techniques. Based on end user, the target market is segmented as hospitals, diagnostic centers, and others.
Breast Imaging Market Size, 2022 To 2030 (USD Million)
AI (GPT) is here !!! Ask questions about Breast Imaging Market
The mammography segment holds the largest market share during the forecast period
The mammography segment in ionizing technology of the global breast imaging market is growing because of many initiatives taken for the early detection of breast cancer. The United States Preventive Services Task Force, for example, has developed guidelines for mammography screening. Moreover, the growing geriatric population and the rising incidence of breast cancer globally will push mammography demand up. According to the American Cancer Society, in the United States, there were 8,130 Ductal carcinomas in situ ( DCIS ) and 37,150 new cases of invasive breast cancer among women aged 40 to 49 years in 2019. The 3D breast tomosynthesis segment is expected to grow at the fastest CAGR during the forecast period because of the rising incidence of breast cancer. This growth is attributable mainly to this technology’s sharp image outputs and reduced recall rates. 3D breast tomosynthesis also overcomes the limitations of standard mammography by allowing detection of all types of lesions.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
Get Access Now
Hospitals segment accounts for the largest market share during the forecast period
Hospitals hold the largest share of the overall breast imaging market in 2020, with a combination of increased spending on healthcare infrastructure, higher purchasing power, more equipped operating and diagnostic rooms, as well as better health coverage for hospital-based healthcare services.
Asia Pacific region dominated the Breast Imaging Market during the forecast period
North America holds largest share of the global breast imaging market in 2017. This is mainly due to rise in prevalence of breast cancer, rising healthcare expenditure, and use of breast imaging as screening. However, Asia Pacific is expected to be the fastest growing region and the segment would grow at a high CAGR during the forecast period. This can be credited to increase in incidence of cancer in this region, as well as increased prevalence of early detection and diagnosis of breast cancer. The increase in the number of healthcare providers and radiology centers is expected to provide impetus to the target market. Additionally, increase in demand for advanced imaging technology including PET-CT and MRI are also driving the global breast imaging market growth in the region. Another key factor fueling the market's growth is frequency of breast screening programs to raise awareness about the importance of early diagnosis in the region.
Competitive Landscape-
Some of the major key players in the breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Inc. (Japan), Siemens Healthineers (Germany), Aurora Healthcare US Corp. (US), Fujifilm Holdings Corporation (Japan), Allengers (India), Dilon Technologies, Inc. (US), Delphinus Medical Technologies, Inc. (US), Planmed Oy (Finland), Micrima Limited (UK), SuperSonic Imagine (France), CMR Naviscan Corporation (US), and Carestream Health (US).
Breast Imaging Market is segmented as follows:
Parameter
Details
Segments Covered
By Type of Imaging Technique
By End Users
By Regions
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Breast Imaging Market is tabulated as follows:
FAQ
Frequently Asked Question
What is the global demand for Breast Imaging in terms of revenue?
-
The global Breast Imaging valued at USD 3897.55 Million in 2022 and is expected to reach USD 6899.62 Million in 2030 growing at a CAGR of 7.40%.
Which are the prominent players in the market?
-
The prominent players in the market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Canon Inc. (Japan), Aurora Healthcare US Corp. (US), Allengers (India), Dilon Technologies, Inc. (US), Planmed Oy (Finland), Delphinus Medical Technologies, Inc. (US), Micrima Limited (UK), CMR Naviscan Corporation (US), SuperSonic Imagine (France), and Carestream Health (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 7.40% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Breast Imaging include
- increasing incidence of breast cancer
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Breast Imaging in 2022.